Toggle light / dark theme

David Chalmers, Professor of Philosophy and Neural Science at NYU, joins us to discuss his newest book Reality+: Virtual Worlds and the Problems of Philosophy.

Topics discussed in this episode include:

-Virtual reality as genuine reality.
–Why VR is compatible with the good life.
–Why we can never know whether we’re in a simulation.
–Consciousness in virtual realities.
–The ethics of simulated beings.

You can find the page for the podcast here: https://futureoflife.org/2022/01/26/david-chalmers-on-realit…hilosophy/

Listen to the audio version of this episode here: https://podcasts.apple.com/us/podcast/david-chalmers-on-real…0549092329

Check out David’s book and website here: http://consc.net/

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

Editorial Disclosure: The author of this article has a business relationship with James Phare, CEO and founder of Neural Alpha.

What does sustainability actually mean for organizations? Can it be measured, and if yes, how so? Often, these are obvious questions with less-than-obvious answers, even for sustainability and environmental, social and governance (ESG) professionals like James Phare.

Glioblastoma is one of the most aggressive types of brain cancer known to man. For many, the chance of survival is often low. However, a new type of brain tumor therapy could help change things for the better. The therapy, which relies on destroying the “power source” of the cancer, has shown considerable success in mice. The scientists are hopeful it will work the same in humans.

The new therapy hopes to destroy the “power source” of glioblastoma tumors. A new study led by Israeli scientists shows that glioblastoma relies on specific brain cells to fuel the growth of its tumors. As a result, scientists began to look at ways to treat cancer by removing those cells instead. The new brain tumor therapy could completely starve out the cancer cells, allowing patients to enter remission.

Normally doctors would use chemotherapy to target the tumors directly. However, by removing brain cells called Astrocytes, scientists found they could starve out glioblastoma tumors in mice. Further, the tumors remained gone for as long as the astrocytes were repressed. And, even when they stopped suppressing, Dr. Lior Mayo, lead author on the study, says that 85 percent of mice stayed in remission.

If anyone has a tiktok you are welcome to follow me or if you want to view some videos I created a Playlist. Just click on the links:

Psychology:

Robert Sapolsky: https://www.tiktok.com/t/ZTRP33D38/

Neuroscience: https://www.tiktok.com/t/ZTRP3P9kC/

Neurological Disorders: https://www.tiktok.com/t/ZTRP3vBs9/

LSD and the Brain: https://www.tiktok.com/t/ZTRP3g1nG/


Everything we do as living organisms is dependent, in some capacity, on time. The concept is so complex that scientists still argue whether it exists or if it is an illusion.

In this video, astrophysicist Michelle Thaller, science educator Bill Nye, author James Gleick, and neuroscientist Dean Buonomano discuss how the human brain perceives of the passage of time, the idea in theoretical physics of time as a fourth dimension, and the theory that space and time are interwoven.

Thaller illustrates Einstein’s theory of relativity, Buonomano outlines eternalism, and all the experts touch on issues of perception, definition, and experience.

In a new study published in Science, researchers have used single-nucleus sequencing (sNuc-Seq) to characterize the cell populations of the axolotl forebrain, an aquatic salamander that can regenerate brain tissue post-injury.

Axolotls – a translational model

The brain is a complex organ, comprising billions of cells and neuronal connections that form intricate networks. Understanding which cells are actively engaged in neurological processes – and which genes underpin this activity – can help us to decipher this complexity. It is only recently that advances in single-cell sequencing have made such research possible, providing insights on the molecular signatures of thousands of individual cells.

Neural Radiance Fields (NeRF) were first developed, greatly enhancing the quality of new vision synthesis. It was first suggested as a way to rebuild a static picture using a series of posed photographs. However, it has been swiftly expanded to include dynamic and uncalibrated scenarios. With the assistance of sizable controlled datasets, recent work additionally concentrate on animating these human radiance field models, thereby broadening the application domain of radiance-field-based modeling to provide augmented reality experiences. In this study, They are focused on the case when just one video is given. They aim to rebuild the human and static scene models and enable unique posture rendering of the person without the need for pricey multi-camera setups or manual annotations.

Neural Actor can create inventive human poses, but it needs several films. Even with the most recent improvements in NeRF techniques, this is far from a simple task. The NeRF models must be trained using many cameras, constant lighting and exposure, transparent backgrounds, and precise human geometry. According to the table below, HyperNeRF cannot be controlled by human postures but instead creates a dynamic scene based on a single video. ST-NeRF uses many cameras to rebuild each person using a time-dependent NeRF model, although the editing is only done to change the bounding box. HumanNeRF creates a human model from a single video with masks that have been carefully annotated; however, it does not demonstrate generalization to novel postures.

With a model trained on a single video, Vid2Actor can produce new human poses, but it cannot model the surroundings. They solve these issues by proposing NeuMan, a system that can create unique human stances and novel viewpoints while reconstructing the person and the scene from a single in-the-wild video. Figure 1’s high-quality pose-driven rendering is made possible by NeuMan, a cutting-edge framework for training NeRF models for both the human and the scene. They first estimate the camera poses, the sparse scene model, the depth maps, the human stance, the human form, and the human masks from a moving camera’s video.

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig’s disease.

In the first trial of its kind, the Cedars-Sinai team showed that delivery of this combined treatment is safe in humans. The findings were reported today in the peer-reviewed journal Nature Medicine.

“Using stem cells is a powerful way to deliver important proteins to the brain or spinal cord that can’t otherwise get through the ,” said senior and corresponding author Clive Svendsen, Ph.D., professor of Biomedical Sciences and Medicine and executive director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute. “We were able to show that the engineered stem cell product can be safely transplanted in the human spinal cord. And after a one-time treatment, these cells can survive and produce an important protein for over three years that is known to protect that die in ALS.”

A study finds that deep brain stimulation to areas of the brain associated with reward and motivation could be used as a potential treatment for depression.

According to researchers at the University of Texas Health Science Center at Houston, deep brain stimulation (DBS) to the superolateral branch of the medial forebrain bundle (MFB), which is linked to motivation and reward, revealed metabolic brain changes over a 12-month period following DBS implantation. This makes it a potent potential therapy for treatment-resistant depression.

The study’s findings, which included 10 patients, were published in the journal Molecular Psychiatry.

The latest study focused on serotonin receptors in the brain, crucial for memory, fear, and attentiveness.

Scientists have discovered a new type of synapse hiding in the brains of mice. Researchers at HHMI’s Janelia Research Campus.

“This special synapse represents a way to change what is being transcribed or made in the nucleus, and that changes whole programs,” said David Clapham, Janelia’s senior group leader.

“The effects in the cell are not just short-term — some can be long-term,” added the study’s lead author.


Whitehoune/iStock.

Researchers at HHMI’s Janelia Research Campus in Ashburn, Virginia, have found this new kind of synapse in the tiny hairs on the surface of mice neurons, according to a press release published by the institute on Thursday.